Announced results from the 12 mg dose cohort (n=16) of the Phase 1b PIONEER trial of pociredir in sickle cell disease (SCD); pociredir was generally well-tolerated with no treatment-related serious ad ...

NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks.Nasdaq most active stocks:Stock NameVolumeHighLowLastChangeHealthcare Triangle Inc.751,724,6000.02850.